Resumo
Introduction: Lung transplantation has become a critical option for patients with advanced cystic fibrosis, a genetic disorder that causes the production of thick and sticky mucus, leading to severe respiratory complications and impaired lung function. Cystic fibrosis results in recurrent lung infections and significant structural damage, making lung transplantation necessary when conventional treatments are no longer sufficient to manage disease progression. In this context, the surgical approach involves not only the replacement of compromised lungs but also the management of specific complications and the adaptation of the patient to the new organ. Objective: To evaluate clinical practices and surgical considerations associated with lung transplantation in patients with cystic fibrosis, focusing on clinical presentations and surgical challenges. Methodology: The systematic review was conducted following the PRISMA checklist to ensure accuracy and transparency. Searches were performed in the PubMed, Scielo, and Web of Science databases. The descriptors used were "cystic fibrosis," "lung transplantation," "clinical presentations," "surgical considerations," and "postoperative outcomes." Inclusion criteria were articles published in the last 10 years, studies focused on patients with cystic fibrosis and lung transplantation, and publications describing both clinical practices and surgical outcomes. Exclusion criteria included studies without relevant data on cystic fibrosis lung transplantation, articles addressing other pulmonary diseases, and reviews or meta-analyses without original data. Results: The reviewed studies indicated that lung transplantation for cystic fibrosis patients is associated with significant improvements in lung function and quality of life. However, the complexity of the surgical procedure and the need for intensive postoperative management were highlighted as critical factors. The surgical approach requires meticulous planning to avoid complications such as graft rejection and infections. Detailed preoperative assessment and rigorous follow-up were identified as essential for long-term transplant success. Conclusion: Lung transplantation represents an effective option for patients with cystic fibrosis who have reached the advanced stage of pulmonary disease. Clinical and surgical practices must be carefully adapted to the specific needs of these patients to optimize outcomes and minimize complications. The integration of robust assessment and follow-up strategies has proven fundamental for transplant success and substantial improvement in patient quality of life.
Referências
Maule G, Arosio D, Cereseto A. Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing. Int J Mol Sci. 2020 May 30;21(11):3903. doi: 10.3390/ijms21113903. PMID: 32486152; PMCID: PMC7313467.
Dell'Anno I, Calabria S, Dondi L, Ronconi G, Dondi L, Addesi A, Pedrini A, Esposito I, Maggioni AP, Martini N, Piccinni C. Pdta Net come strumento per l’analisi dei percorsi regionali delle malattie rare: l’esempio della fibrosi cistica. Recenti Prog Med. 2023 Sep;114(9):534-535. Italian. doi: 10.1701/4088.40801. PMID: 37530008.
Miraglia Del Giudice M, Allegorico A, Marseglia GL, Martelli A, Calvani M, Cardinale F, Duse M, Chiappini E, Manti S, Cravidi C, Tosca MA, Caffarelli C. Allergic rhinoconjunctivitis. Acta Biomed. 2020 Sep 15;91(11-S):e2020007. doi: 10.23750/abm.v91i11-S.10310. PMID: 33004777; PMCID: PMC8023069.
Licari A, Manti S, Leonardi S, Minasi D, Caffarelli C, Cardinale F, Miraglia Del Giudice M, Calvani M, Ciprandi G, Marseglia GL. Biologic drugs in chronic spontaneous urticaria. Acta Biomed. 2021 Nov 29;92(S7):e2021527. doi: 10.23750/abm.v92iS7.12415. PMID: 34842589; PMCID: PMC9431883.
Manti S, Licari A, Montagna L, Votto M, Leonardi S, Brambilla I, Castagnoli R, Foiadelli T, Marseglia GL, Cardinale F, Caffarelli C, Tosca MA, Cravidi C, Duse M, Chiappini E. SARS-CoV-2 infection in pediatric population. Acta Biomed. 2020 Sep 15;91(11-S):e2020003. doi: 10.23750/abm.v91i11-S.10298. PMID: 33004773; PMCID: PMC8023063.
Reis FJ, Damaceno N. Fibrose cística [Cystic fibrosis]. J Pediatr (Rio J). 1998 Jul;74 Suppl 1:S76-94. Portuguese. doi: 10.2223/jped.489. PMID: 14685577.
Angyal D, Bijvelds MJC, Bruno MJ, Peppelenbosch MP, de Jonge HR. Bicarbonate Transport in Cystic Fibrosis and Pancreatitis. Cells. 2021 Dec 24;11(1):54. doi: 10.3390/cells11010054. PMID: 35011616; PMCID: PMC8750324.
Martelli A, Ippolito R, Votto M, De Filippo M, Brambilla I, Calvani M, Cardinale F, Chiappini E, Duse M, Manti S, Marseglia GL, Caffarelli C, Cravidi C, Miraglia Del Giudice M, Tosca MA. What is new in anaphylaxis? Acta Biomed. 2020 Sep 15;91(11-S):e2020005. doi: 10.23750/abm.v91i11-S.10308. PMID: 33004775; PMCID: PMC8023066.
Liessi N, Pedemonte N, Armirotti A, Braccia C. Proteomics and Metabolomics for Cystic Fibrosis Research. Int J Mol Sci. 2020 Jul 30;21(15):5439. doi: 10.3390/ijms21155439. PMID: 32751630; PMCID: PMC7432297.
Rossin F, Ciccosanti F, D'Eletto M, Occhigrossi L, Fimia GM, Piacentini M. Type 2 transglutaminase in the nucleus: the new epigenetic face of a cytoplasmic enzyme. Cell Mol Life Sci. 2023 Jan 25;80(2):52. doi: 10.1007/s00018-023-04698-8. PMID: 36695883; PMCID: PMC9874183.
Averna M, Melotti P, Sorio C. Revisiting the Role of Leukocytes in Cystic Fibrosis. Cells. 2021 Dec 1;10(12):3380. doi: 10.3390/cells10123380. PMID: 34943888; PMCID: PMC8699441.
Scoffone VC, Barbieri G, Irudal S, Trespidi G, Buroni S. New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis. Antibiotics (Basel). 2024 Jan 11;13(1):71. doi: 10.3390/antibiotics13010071. PMID: 38247630; PMCID: PMC10812592.
Adde FV. Nutrição em fibrose cística: tão importante quanto o manejo da doença pulmonar [Nutrition in Cystic Fibrosis: as important as the pulmonary management]. Rev Paul Pediatr. 2015 Jan-Mar;33(1):1-2. doi: 10.1016/j.rpped.2014.12.001. Epub 2015 Jan 23. PMID: 25623727; PMCID: PMC4436949.
Munck A, Berger DO, Southern KW, Carducci C, de Winter-de Groot KM, Gartner S, Kashirskaya N, Linnane B, Proesmans M, Sands D, Sommerburg O, Castellani C, Barben J; European CF Society Neonatal Screening Working Group (ECFS NSWG). European survey of newborn bloodspot screening for CF: opportunity to address challenges and improve performance. J Cyst Fibros. 2023 May;22(3):484-495. doi: 10.1016/j.jcf.2022.09.012. Epub 2022 Nov 10. PMID: 36372700.
Chiavetta RF, Titoli S, Barra V, Cancemi P, Melfi R, Di Leonardo A. Site-Specific RNA Editing of Stop Mutations in the CFTR mRNA of Human Bronchial Cultured Cells. Int J Mol Sci. 2023 Jun 30;24(13):10940. doi: 10.3390/ijms241310940. PMID: 37446121; PMCID: PMC10342162.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Roberta Cristina Lourençoni Ribeiro, Eduardo Henrique Mendes Rezende, Matheus Martins Bonacasata, Igor Costa Santos, Izabella Trevisan Alves, Vinicius Trevisan Alves